The fall of Beijing, extraordinarily beautiful, beautiful, makes you unable to write where to praise this ancient civilization of the era of the city. This weekend, because of the grand convening of the "2018 China Medical Device Innovation and Entrepreneurship Conference", the decoration of Beijing is particularly beautiful.
On November 3, 2018, the "2018 China Medical Device Innovation and Entrepreneurship Conference" was held in Beijing Zhongguancun National Independent Innovation Demonstration Zone Conference Center. More than 300 medical colleagues from scientific research, clinical, corporate, and investment circles attended the conference. Everyone gathered together to discuss the cross-border integration of medical device industry resources, help innovation and clinical application and capital docking, promote the transformation of medical device innovation achievements, continue to promote the "double innovation" activities, and implement the innovation-driven development strategy.
The conference is divided into three sub-sites of intelligent medical equipment, advanced treatment and in vitro diagnosis, including orthopedic surgery robot, flow fluorescence technology, micro medical imaging module, ophthalmic OTC, domestic targeted kit, MMC rapid detector, cranial 34 innovative projects such as the minimally invasive system of internal hematoma participated in the road show. After the final selection, three companies including An Ying Technology (Beijing) Co., Ltd. were rated as the most investment value projects, and six companies including Beijing Zhizheng Net Technology Co., Ltd. were rated as the most investment potential projects.
In addition, the conference site built an industrial resource docking channel, attracting the world's leading medical device service provider NAMSA, Swiss design service provider Helbling, medical device third-party service platform AOSTA Medical Device Service Group, WuXi PharmaTech medical device testing Service Department, domestic efficient clinical research and development management platform, light medical care, medical equipment professional park Zhongguancun Medical Equipment Park, investment incubation platform and Yiguang Industry Innovation Platform, R&D institution Beijing Natong Medical Science and Technology Research Institute and some innovative project companies Huarui, in vitro The diagnostic manufacturer Jingtian Medical, non-invasive arterial blood pressure measuring instrument, Kang Kangzheng and other on-site display, covering all aspects of industrial ecology from investment and financing, design and development verification, registration services, industrial production (park). I hope to bring a grand meeting of all-industry and full-industry chain participants.
The conference was sponsored by the China National Institute of Biomedical Engineering, Nankai University and Beijing Natong Technology Group Co., Ltd., supported by the Management Committee of Haidian Park of Zhongguancun Science and Technology Park. The Science and Technology Innovation and Industry Promotion Committee of China Biomedical Engineering Society, Beijing and Yiguang Industry Innovation Platform undertakes.
Ms. Li Dongming from the Haidian District Government, Liang Aixiang, the exhibition and trading center of the Zhongguancun National Independent Innovation Demonstration Zone, Zhang Xu, the medical project department of the Biomedical Division of the Beijing Municipal Science and Technology Commission, Wang Guangzhi, the vice chairman of the China Biomedical Engineering Society, and the vice chairman of Wan Haoren. Secretary Chi Hui and other leaders attended the event.
"I hope that through this conference, we can attract and explore a group of innovative entrepreneurial projects and industrial service resources with significant clinical value and great transformation value, and make full use of the existing intellectual resources and technological reserve advantages in the Haidian region. Industrial development creates a better entrepreneurial ecology.” At the opening ceremony of the conference, Ms. Li Dongming expressed her ardent expectations for promoting the rapid and sustainable development of China's medical device industry.
Ms. Chi Hui, Secretary-General of the Chinese Society of Biomedical Engineering, pointed out that in order to transform the current enterprise's single and discrete innovation into industry collaborative innovation and create a collaborative environment for the network ecological space, the Society held the conference and played the national society. Resource advantages, gathering experts and industry wisdom, seamlessly connecting the needs of innovative and entrepreneurial enterprises, and exploring a number of valuable and promising projects for medical innovation and clinical transformation.
Mr. Dong Wei, general manager of Heyi Guangye Innovation Platform, said in his speech that open, collaborative and integrated innovation has gradually become the dominant mode of innovation and the trend of global development. The conference will join hands with domestic and foreign medical device start-ups and domestic and overseas industrial service providers to initiate the reconstruction of the innovation of the medical device industry, to create the original source of innovation for medical device research and development, and finally form a China based on Haidian, Beijing, and the whole country. Medical device innovation ecosystem.
Ms. Li Dongming, Haidian District Government
Ms. Chi Hui, Secretary General of China Biomedical Engineering Society
The lineup of expert judges participating in this event is very strong. Each of the venues invited two academic experts, one business community expert and two investment experts to form an expert jury to conduct on-site reviews of the project from different angles. Professor Wan Yiren from Southeast University, Prof. Yan Tingfei, Director of Biomedical Materials and Tissue Engineering Center of Peking University's Frontier Interdisciplinary Research Institute, Professor Gao Xiaoyu, Department of Biomedical Engineering, Tsinghua University School of Medicine, Professor Kang Xixiong, Experimental Diagnostic Center of Beijing Tiantan Hospital, and Founding of Yanshi Assets Managing Partner Yang Yigang, Managing Director of Huagai Medical Fund Shi Guomin, Managing Partner of Gao Tejia Investment Group Zhang Peng, Chairman of Yi'an Medical Group Li Changchun, and Director of Research and Development of Ultrasound Imaging System of Shenzhen Mindray Medical Electronics Co., Ltd. Zhu Lei and other academic circles, The big friends in the investment and industry circles gathered together and served as judges.
Professor Gao Xiaoyu, Department of Biomedical Engineering, Tsinghua University School of Medicine